Glen R. Anderson is 10% Owner at Indaptus Therapeutics, Inc. (INDP). They have made 1 open-market trade across 1 company since 2023, most recently 2023-08-14.
CIK 0001878961
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $433K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INDP | 1,131,402 | $3.1M |
Shares reported on the most recent Form 4, priced at the 2023-08-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INDP | BUY | 2023-08-10 | 2023-08-16 | $2.09 | $433K | +10.0% | +47.6% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.